The Department of Defense relies on hundreds, if not thousands, of weapons and products such as uniforms, batteries, and microelectronics that contain PFAS, a family of chemicals linked to serious health conditions.
BIO-Europe 2023: Small oncology biotechs require creative financing approaches – Pharmaceutical Technology
The panel discussion featuring (L-R) Lucie Ellis-Taitt, executive director In Vivo Citeline, Jean-Paul Kress, CEO, Morphosys and Susanne Schaffert, board director, Novo Holding, Incyte, Galapagos,